Literature DB >> 23167434

The effects of whey protein on cardiometabolic risk factors.

Sebely Pal1, Simone Radavelli-Bagatini.   

Abstract

Obesity has reached epidemic proportions worldwide. The health consequences of obesity are more dangerous when associated with the metabolic syndrome and its components. Studies show that whey protein and its bioactive components can promote greater benefits compared to other protein sources such as egg and casein. The aim of this paper is to review the effects of whey protein on cardiometabolic risk factors. Using PubMed as the database, a review was conducted to identify current scientific literature on whey protein and the components of the metabolic syndrome published between 1970 and 2012. Consumption of whey protein seems to play an anti-obesity and muscle-protective role during dieting by increasing thermogenesis and maintaining lean mass. In addition, whey protein has been shown to improve glucose levels and insulin response, promote a reduction in blood pressure and arterial stiffness, and improve lipid profile. The collective view of current scientific literature indicates that the consumption of whey protein may have beneficial effects on some symptoms of the metabolic syndrome as well as a reduction in cardiovascular risk factors.
© 2012 The Authors. obesity reviews © 2012 International Association for the Study of Obesity.

Entities:  

Keywords:  Cardiovascular disease; dairy whey protein; metabolic syndrome; obesity

Mesh:

Substances:

Year:  2012        PMID: 23167434     DOI: 10.1111/obr.12005

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  23 in total

Review 1.  Effects of dairy protein and fat on the metabolic syndrome and type 2 diabetes.

Authors:  Ann Bjørnshave; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2014-08-10

Review 2.  Associations between dairy foods, diabetes, and metabolic health: potential mechanisms and future directions.

Authors:  Kristin M Hirahatake; Joanne L Slavin; Kevin C Maki; Sean H Adams
Journal:  Metabolism       Date:  2014-02-17       Impact factor: 8.694

Review 3.  The role of nutrition and nutraceutical supplements in the treatment of hypertension.

Authors:  Mark Houston
Journal:  World J Cardiol       Date:  2014-02-26

4.  Comparative effects of whey and casein proteins on satiety in overweight and obese individuals: a randomized controlled trial.

Authors:  S Pal; S Radavelli-Bagatini; M Hagger; V Ellis
Journal:  Eur J Clin Nutr       Date:  2014-05-07       Impact factor: 4.016

5.  Dairy intake and incident functional disability among older Japanese adults: the Ohsaki Cohort 2006 Study.

Authors:  Yukai Lu; Sanae Matsuyama; Yumi Sugawara; Toshimasa Sone; Ichiro Tsuji
Journal:  Eur J Nutr       Date:  2022-03-04       Impact factor: 4.865

6.  Dairy product consumption and its association with metabolic disturbance in a prospective study of urban adults.

Authors:  May A Beydoun; Marie T Fanelli-Kuczmarski; Hind A Beydoun; Greg A Dore; Jose A Canas; Michele K Evans; Alan B Zonderman
Journal:  Br J Nutr       Date:  2018-03       Impact factor: 3.718

Review 7.  Effect of whey protein on blood lipid profiles: a meta-analysis of randomized controlled trials.

Authors:  J-W Zhang; X Tong; Z Wan; Y Wang; L-Q Qin; I M Y Szeto
Journal:  Eur J Clin Nutr       Date:  2016-03-30       Impact factor: 4.016

Review 8.  Nutrition and nutraceutical supplements for the treatment of hypertension: part II.

Authors:  Mark Houston
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-04       Impact factor: 3.738

9.  Milk protein for improved metabolic health: a review of the evidence.

Authors:  Robin A McGregor; Sally D Poppitt
Journal:  Nutr Metab (Lond)       Date:  2013-07-03       Impact factor: 4.169

10.  The effects of whey protein with or without carbohydrates on resistance training adaptations.

Authors:  Juha J Hulmi; Mia Laakso; Antti A Mero; Keijo Häkkinen; Juha P Ahtiainen; Heikki Peltonen
Journal:  J Int Soc Sports Nutr       Date:  2015-12-16       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.